Literature DB >> 10601721

Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention.

B N Singh1, K H Kim.   

Abstract

In recent years scientific and technological advancements have been made in the research and development of rate-controlled oral drug delivery systems by overcoming physiological adversities, such as short gastric residence times (GRT) and unpredictable gastric emptying times (GET). Several approaches are currently utilized in the prolongation of the GRT, including floating drug delivery systems (FDDS), also known as hydrodynamically balanced systems (HBS), swelling and expanding systems, polymeric bioadhesive systems, modified-shape systems, high-density systems, and other delayed gastric emptying devices. In this review, the current technological developments of FDDS including patented delivery systems and marketed products, and their advantages and future potential for oral controlled drug delivery are discussed.

Entities:  

Mesh:

Year:  2000        PMID: 10601721     DOI: 10.1016/s0168-3659(99)00204-7

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  95 in total

1.  Novel application of MRI technique combined with flow-through cell dissolution apparatus as supportive discriminatory test for evaluation of controlled release formulations.

Authors:  Przemyslaw P Dorozyński; Piotr Kulinowski; Aleksander Mendyk; Anna Młynarczyk; Renata Jachowicz
Journal:  AAPS PharmSciTech       Date:  2010-03-30       Impact factor: 3.246

2.  Gastroretentive drug delivery system of ranitidine hydrochloride: formulation and in vitro evaluation.

Authors:  Brijesh S Dave; Avani F Amin; Madhabhai M Patel
Journal:  AAPS PharmSciTech       Date:  2004-04-08       Impact factor: 3.246

Review 3.  Floating drug delivery systems: a review.

Authors:  Shweta Arora; Javed Ali; Alka Ahuja; Roop K Khar; Sanjula Baboota
Journal:  AAPS PharmSciTech       Date:  2005-10-19       Impact factor: 3.246

4.  Evaluation of porous carrier-based floating orlistat microspheres for gastric delivery.

Authors:  Sunil K Jain; Govind P Agrawal; Narendra K Jain
Journal:  AAPS PharmSciTech       Date:  2006-11-10       Impact factor: 3.246

Review 5.  Oral bioavailability: issues and solutions via nanoformulations.

Authors:  Kamla Pathak; Smita Raghuvanshi
Journal:  Clin Pharmacokinet       Date:  2015-04       Impact factor: 6.447

6.  Gauge repeatability and reproducibility for accessing variability during dissolution testing: a technical note.

Authors:  Zongming Gao; Terry Moore; Anjanette P Smith; William Doub; Benjamin Westenberger; Lucinda Buhse
Journal:  AAPS PharmSciTech       Date:  2007-10-12       Impact factor: 3.246

7.  Development and evaluation of sustained release gastroretentive minimatrices for effective treatment of H. pylori infection.

Authors:  Atul C Badhan; Rajashree C Mashru; Punit P Shah; Arti R Thakkar; Nitin B Dobaria
Journal:  AAPS PharmSciTech       Date:  2009-04-21       Impact factor: 3.246

8.  Gastroretentive hydrodynamically balanced systems of ofloxacin: In vitro evaluation.

Authors:  Amit Kumar Nayak; Biswarup Das; Ruma Maji
Journal:  Saudi Pharm J       Date:  2011-11-22       Impact factor: 4.330

9.  Effect of pH on sublingual absorption of oxycodone hydrochloride.

Authors:  Abeer M Al-Ghananeem; Ahmad H Malkawi; Peter A Crooks
Journal:  AAPS PharmSciTech       Date:  2006-03-10       Impact factor: 3.246

10.  Development of Gelucire 43/01 beads of metformin hydrochloride for floating delivery.

Authors:  Sunil K Jain; Anuj Gupta
Journal:  AAPS PharmSciTech       Date:  2009-10-15       Impact factor: 3.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.